Increased levels of catalase and cathepsin V/L2 but decreased TIMP-1 in keratoconus corneas: Evidence that oxidative stress plays a role in this disorder

被引:175
作者
Kenney, MC
Chwa, M
Atilano, SR
Tran, A
Carballo, M
Saghizadeh, M
Vasiliou, V
Adachi, W
Brown, DJ
机构
[1] Univ Calif Irvine, Med Ctr, Dept Ophthalmol, Orange, CA 92868 USA
[2] Univ Calif Los Angeles, Jules Stein Eye Inst, Los Angeles, CA 90024 USA
[3] Univ Colorado, Hlth Sci Ctr, Mol Toxicol & Environm Hlth Sci Program, Denver, CO USA
[4] Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, Japan
[5] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
关键词
D O I
10.1167/iovs.04-0549
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE. The mRNA levels of antioxidant enzymes, matrix metalloproteinases, cathepsin V/1,2, and tissue inhibitor of matrix metalloproteinases (TIMPs) were determined in keratoconus and normal corneas. Protein levels or enzyme activities were analyzed when RNA levels were different. METHODS. A total of 25 physiologic (normal) and 32 keratoconus corneas were studied. mRNAs were analyzed by semiquantitative reverse transcription-polymerase chain reaction and Southern blot analysis. Proteins were assessed by immunohistochemistry and/or Western blot analysis. Catalase activity was measured in corneal extracts. Antioxidant enzymes examined were catalase, superoxide dismutase (SOD)-1, SOD3, glutathione reductase, glutathione S-transferase and aldehyde dehydrogenase 3A1. Degradative enzymes examined were cathepsin V/L2 and matrix metalloproteinase (MMP)-1, -2, -7, -9, and -14. Tissue inhibitor of matrix metalloproteinase (TIMP)-1, -2, and -3 were also examined. RESULTS. Keratoconus corneas exhibited a 2.2-fold increase of catalase mRNA level (P < 0.01) and 1.8-fold of enzyme activity (P < 0.03); a 1.5-fold increase of cathepsin V/L2 mRNA (P < 0.03) and abnormal protein distribution; and a 1.8-fold decrease of TIMP-1 mRNA (P < 0.05) and 2.8-fold decrease of protein (P < 0.0001) compared with normal (physiologic) corneas. RNA levels for other antioxidant and degradative enzymes were similar between normal and keratoconus corneas. CONCLUSIONS. Keratoconus corneas have elevated levels of cathepsins V/L2, -B, and -G, which can stimulate hydrogen peroxide production, which, in turn, can upregulate catalase, an antioxidant enzyme. In addition, decreased TIMP-1 and increased cathepsin V/L2 levels may play a role in the matrix degradation that is a hallmark of keratoconus corneas. The findings support the hypothesis that keratoconus corneas undergo oxidative stress and tissue degradation.
引用
收藏
页码:823 / 832
页数:10
相关论文
共 77 条
  • [41] Keratocyte apoptosis associated with keratoconus
    Kim, WJ
    Rabinowitz, YS
    Meisler, DM
    Wilson, SE
    [J]. EXPERIMENTAL EYE RESEARCH, 1999, 69 (05) : 475 - 481
  • [42] Characteristics of the human ocular surface epithelium
    Kinoshita, S
    Adachi, W
    Sotozono, C
    Nishida, K
    Yokoi, N
    Quantock, AJ
    Okubo, K
    [J]. PROGRESS IN RETINAL AND EYE RESEARCH, 2001, 20 (05) : 639 - 673
  • [43] KERATOCONUS AND RELATED NONINFLAMMATORY CORNEAL THINNING DISORDERS
    KRACHMER, JH
    FEDER, RS
    BELIN, MW
    [J]. SURVEY OF OPHTHALMOLOGY, 1984, 28 (04) : 293 - 322
  • [44] AMPLIFICATION AND HYPEREXPRESSION OF THE CATALASE GENE IN SELENOPEROXIDASE-DEFICIENT LEUKEMIA-CELLS
    LIN, FB
    JACKSON, VE
    GIROTTI, AW
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1995, 317 (01) : 7 - 18
  • [45] MILLIN JA, 1986, INVEST OPHTH VIS SCI, V27, P604
  • [46] Peroxynitrite: A biologically significant oxidant
    Murphy, MP
    Packer, MA
    Scarlett, JL
    Martin, SW
    [J]. GENERAL PHARMACOLOGY, 1998, 31 (02): : 179 - 186
  • [47] Nelson KK, 2003, CLIN CANCER RES, V9, P424
  • [48] CHARACTERIZATION OF A HUMAN CORNEAL METALLOPROTEINASE INHIBITOR (TIMP-1)
    OPBROEK, A
    KENNEY, MC
    BROWN, D
    [J]. CURRENT EYE RESEARCH, 1993, 12 (10) : 877 - 883
  • [49] Human aldehyde dehydrogenase 3A1 (ALDH3A1): biochemical characterization and immunohistochemical localization in the cornea
    Pappa, A
    Estey, T
    Manzer, R
    Brown, D
    Vasiliou, V
    [J]. BIOCHEMICAL JOURNAL, 2003, 376 : 615 - 623
  • [50] Keratoconus
    Rabinowitz, YS
    [J]. SURVEY OF OPHTHALMOLOGY, 1998, 42 (04) : 297 - 319